Seong-Soo Park
Vermögen: 78 295 $ am 30.09.2026
Vermögen: 78 295 $ am 30.09.2026
Mr. Seong-Soo Park is an Independent Director at AEON Biopharma, Inc., a Chairman at Daewoong Co., Ltd. and a Co-Chief Executive Officer & Director at Daewoong Pharmaceutical Co., Ltd. He is on the Board of Directors at AEON Biopharma, Inc., Daewoong Pharmaceutical Co., Ltd. and In Therapeutics Co. Ltd. He received his undergraduate degree from Seoul National University and a graduate degree from Seoul National University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DAEWOONG CO., LTD. 0.01% | 26.03.2026 | 7’032 ( 0.01% ) | 78 295 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AEON BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 12.04.2024 |
| DAEWOONG PHARMACEUTICAL CO., LTD | Vorstandsvorsitzender | 28.03.2024 |
| DAEWOONG CO., LTD. | Vorsitzender | - |
In Therapeutics
In Therapeutics Packaged SoftwareTechnology Services Operates a drug development platform | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Daewoong Co., Ltd.
Daewoong Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Daewoong Pharmaceutical Co., Ltd.
Daewoong Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
In Therapeutics
In Therapeutics Packaged SoftwareTechnology Services Operates a drug development platform | Technology Services |
AEON Biopharma, Inc.
AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen